REGENERON

Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders

Research and development of pharmaceutical preparations; Genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies; Genetic engineering services, namely, deletion and modification of genes for others, and production of genetically modified animals; Genetic research; Genetic engineering services for genes, cells, and animals using non-human embryonic stem cells (ES) and non-human embryo manipulation technology for rapid development of genetically modified non-human animals

Providing medical information and treatment support programs in the nature of medical information via the telephone and the internet for professionals, patients, consumers, and the general public regarding pharmaceutical products and services